Global Medical Syringe Market Size By Type (Blood Collection Syringe, Ophthalmic Syringe, Bone Marrow Syringe, Catheter Syringe, and Others), Usability (Disposable, and Reusable), End User (Hospitals and Diagnostic Laboratories, Blood Banks, Pharmaceutical Industry, Veterinary Purposes, and Others), and Region - Market Share, Trend Analysis, Competitive Intelligence, Historical Data, and Forecast 2023 - 2030

Market Perspective

The global Medical Syringe Market was worth USD 15.48 billion in 2022 and is anticipated to grow to USD 33.00 billion by 2030 at a CAGR of around 10.11% between 2023 and 2030.

A medical syringe is a crucial medical instrument designed for the precise measurement and administration of medications, vaccines, and other medical fluids into the human body.

The global medical syringe market is experiencing substantial growth due to the increasing prevalence of chronic diseases requiring regular injections for testing and dosage. For instance, the rising demand for vaccines during the COVID-19 pandemic resulted in a significant surge in the demand for medical syringes.

Additionally, the market is witnessing trends such as the adoption of prefilled syringes for convenience and reduced dosage errors, a shift toward sustainable and eco-friendly types in syringe manufacturing, and the expansion of healthcare infrastructure in emerging economies. The medical syringe market is estimated to continue its upward trajectory, driven by the ongoing need for injections and advancements in syringe technologies, including the development of smart syringes with digital features for monitoring and data collection.

Moreover, the R&D efforts, the implementation of strategic models, and the collaboration among market players support the expansion of the market in both developed and developing countries. North America, Europe, and Asia-Pacific are key contributors to the significant revenues and opportunities for the companies operating in the market.

Key Insights

• Based on type, the blood collection syringe segment held the dominating position in 2022
• Based on usability, the disposable segment acquired the largest market share in 2022
• Based on end user, the hospitals segment is expected to grow at the highest CAGR over the forecast period
• On the basis of region, Asia-Pacific accounted for the largest market share in 2022

Rising Demand for Vaccines to Fuel Medical Syringe Market Growth

The increasing demand for vaccines, particularly in the wake of the COVID-19 pandemic, serves as a significant factor supporting the growth of the medical syringe market. The surge in vaccine production and distribution has created an unprecedented need for syringes.

Governments and healthcare organizations worldwide are prioritizing vaccination as a key public health measure. Vaccines are regarded as a cost-effective way to prevent diseases and alleviate the burden on healthcare systems. This emphasis on vaccination programs has led to a surge in demand for syringes, as they are essential for the administration of vaccines. Additionally, international initiatives, such as the World Health Organization's Expanded Program on Immunization, are dedicated to enhancing vaccine access in low-income countries. These efforts aim to bridge the gap and ensure that vaccines are accessible to populations that need them the most. This global initiative to increase vaccine coverage further contributes to the rising demand for syringes.

Furthermore, the global population is steadily growing, resulting in a higher demand for vaccines as more people require immunization. This population growth, coupled with the increasing awareness of the importance of vaccination, drives the need for syringes to administer vaccines effectively.

Environmental Concerns and Disposable Syringes to Impede Market Development

One of the factors restraining the growth of the medical syringe market is the growing environmental concern related to disposable syringes. While disposable syringes are convenient and hygienic, they contribute to plastic waste, which can be harmful to the environment due to improper waste management. This concern has led to an effort to incorporate more sustainable and eco-friendly materials into the manufacturing of syringes. Manufacturers are exploring options to reduce the environmental footprint of medical syringes. However, this transition may present major challenges, including higher production costs and the need for regulatory approvals for new materials.

Recent Development

January 2022 (Acquisition) - ICU Medical Inc. successfully completed the acquisition of Smiths Medical from Smiths Group plc. With this acquisition, ICU Medical incorporates Smiths Medical's portfolio, which encompasses syringe and ambulatory infusion devices, vascular access, and vital care products. By merging these businesses with ICU Medical's existing operations, the united companies form a prominent infusion therapy entity, projected to generate approximately USD 2.5 billion in combined revenues, according to estimates.

July 2022 (Acquisition) - Sharps Technology successfully finalized its purchase of Safeguard Medical's syringe manufacturing facility in Hungary. The acquisition was valued at USD 2.5 million. Sharps intends to expand the manufacturing capacity of the facility and utilize it to meet the increasing demand for their smart safety syringes. This strategic move by Sharps positions them to capitalize on the growing market and strengthen their presence in the industry.

Segmentation Analysis

Based on type, the market is segmented into blood collection syringes, ophthalmic syringe, bone marrow syringes, and others. The blood collection syringe segment generated the highest revenue share of 39.75% in 2022. Blood collection syringe packaging emerged as the dominating segment as it maintains gas & moisture barriers while also providing airtightness. The Type of syringes used in the manufacture of blood collection syringe packaging is further selected on the basis of hygienic and high-quality types. Moreover, the odor-resistant properties of blood collection syringe packaging have accelerated the growth of the segment. Moreover, the bone marrow syringe segment is growing due to the increased use in the packaging industry. the cost-effective features provided by the use of bone marrow syringes for packaging contributed significantly to the growth of the market.

Based on usability, the market is classified into disposable, reusable, pouches, tins, clamshells and blisters, and others. The reusable segment is experiencing significant growth owing to the availability of a wide range of products that maintain quality and transparency, thereby supporting the expansion of the segment. Furthermore, the growth of the segment is facilitated by its excellent features such as moisture and gas barrier to the packaged product.

Asia-Pacific Emerges as the Dominating Region Due to Increasing Awareness of Advantages Offered by Syringes

The Asia-Pacific region has emerged as the largest market for medical syringes, driven by several key factors such as increasing awareness of the benefits of syringes, improving economic conditions, rising purchasing power, and a sizable population suffering from chronic diseases. Additionally, the COVID-19 pandemic has led to a surge in demand for syringes in the region..

Furthermore, the COVID-19 outbreak has significantly impacted the market outlook, with a higher demand for syringes due to  the rising number of individuals being admitted to hospitals. These hospital admissions require various tests involving collection of blood samples and injections of patients to diagnose COVID-19, which further drives the growth of the medical syringe market in the Asia-Pacific region.

North America to Register Significant Share Owing to Presence of Advanced Healthcare Infrastructure

North America holds a significant revenue share in the global medical syringes market due to various factors that contribute to its growth and dominance in the region. The presence of a well-established healthcare infrastructure, which includes advanced medical facilities, research institutions, and a robust regulatory framework are fostering the market growth. These factors create a favorable environment for the development and adoption of medical syringes. Additionally, the region demonstrates a high level of awareness and acceptance of advanced healthcare technologies, including syringes. This is supported by a well-informed population and a strong healthcare system that emphasizes the importance of safe and effective medical devices.

Furthermore, the increasing prevalence of chronic diseases and the rising geriatric population in North America have led to a greater demand for medical syringes. These syringes are crucial for administering medications, and vaccines, and managing various medical procedures. The regional market growth is further driven by technological advancements and innovations in the field. Companies in the region are continuously investing in research and development to develop syringes that are more user-friendly, accurate, and minimize the risk of contamination.

Moreover, the COVID-19 pandemic has accelerated the demand for medical syringes in North America. The deployment of mass vaccination campaigns and the need for effective testing and treatment have significantly increased the usage of syringes in healthcare settings.

Competitive Landscape

The global medical syringe market is fragmented with key players such as Gerresheimer AG, SCHOTT AG, West Pharmaceutical Services Inc., Pentaferte, Nipro PharmaPackaging International, AptarGroup, Inc., Terumo Corporation, Becton Dickinson and Company, B. Braun Medical Inc., Hindustan Syringes & Medical Devices Limited, Smiths Medical, and Cardinal Health Inc.. Companies employ a variety of strategic measures such as acquisitions, mergers, partnerships, product introductions, and collaborations to expand their business globally and enhance their competitive position.

The global Medical Syringe Market is segmented as follows:

By Type

• Blood Collection Syringe
• Ophthalmic Syringe
• Bone Marrow Syringe
• Catheter Syringe
• Others

By Usability

• Disposable
• Reusable

By End User

• Hospitals
• Diagnostic Laboratories
• Blood Banks
• Pharmaceutical Industry
• Veterinary Purposes
• Others

By Region

• North America
• U.S.
• Canada
• Mexico
• Europe
• Germany
• U.K.
• France
• Italy
• Spain
• Russia
• Rest of Europe
• Asia-Pacific
• China
• Japan
• India
• South Korea
• Rest of Asia-Pacific
• Middle East & Africa
• GCC
• South Africa
• North America
• Rest of Middle East & Africa
• Latin America
• Brazil
• Argentina
• Rest of Latin America